Division of Radiation Oncology, Department of Radiology, Faculty of Medicine, Chulalongkorn University, 1873 Rama IV Road, Pathumwan District, Bangkok 10330, Thailand.
Department of Anatomy, Faculty of Dentistry, Mahidol University, No. 6, Yothi Road, Ratchathewi District, Bangkok 10400, Thailand.
J Radiat Res. 2024 Jan 19;65(1):119-126. doi: 10.1093/jrr/rrad091.
Radiation-induced hypothyroidism (RHT) is a common long-term complication for nasopharyngeal carcinoma (NPC) survivors. A model using clinical and dosimetric factors for predicting risk of RHT could suggest a proper dose-volume parameters for the treatment planning in an individual level. We aim to develop a multivariable normal tissue complication probability (NTCP) model for RHT in NPC patients after intensity-modulated radiotherapy or volumetric modulated arc therapy. The model was developed using retrospective clinical data and dose-volume data of the thyroid and pituitary gland based on a standard backward stepwise multivariable logistic regression analysis and was then internally validated using 10-fold cross-validation. The final NTCP model consisted of age, pretreatment thyroid-stimulating hormone and mean thyroid dose. The model performance was good with an area under the receiver operating characteristic curve of 0.749 on an internal (200 patients) and 0.812 on an external (25 patients) validation. The mean thyroid dose at ≤45 Gy was suggested for treatment plan, owing to an RHT incidence of 2% versus 61% in the >45 Gy group.
放射性甲状腺功能减退症(RHT)是鼻咽癌(NPC)幸存者的常见长期并发症。使用临床和剂量学因素预测 RHT 风险的模型可以在个体水平上为治疗计划建议适当的剂量-体积参数。我们旨在为接受调强放疗或容积旋转调强放疗的 NPC 患者开发一种用于 RHT 的多变量正常组织并发症概率(NTCP)模型。该模型使用回顾性临床数据和甲状腺和垂体的剂量-体积数据,基于标准的向后逐步多变量逻辑回归分析进行开发,然后使用 10 倍交叉验证进行内部验证。最终的 NTCP 模型由年龄、治疗前促甲状腺激素和平均甲状腺剂量组成。该模型在内部(200 例患者)和外部(25 例患者)验证中的受试者工作特征曲线下面积分别为 0.749 和 0.812,表现良好。由于 >45Gy 组的 RHT 发生率为 2%,而 ≤45Gy 组的发生率为 61%,因此建议将 45Gy 作为治疗计划的平均甲状腺剂量。